Literature DB >> 23148175

Response to dr simes and dr snabes.

Rosemary Basson.   

Abstract

Year:  2011        PMID： 23148175      PMCID： PMC3474628          DOI： 10.1177/2042018811405705

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN： 2042-0188            Impact factor:   3.565


× No keyword cloud information.
  9 in total

1.  Role of androgens in women's sexual dysfunction.

Authors:  Rosemary Basson; Lori A Brotto; A John Petkau; Fernand Labrie
Journal:  Menopause       Date:  2010 Sep-Oct       Impact factor: 2.953

2.  Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.

Authors:  F Labrie; A Bélanger; L Cusan; J L Gomez; B Candas
Journal:  J Clin Endocrinol Metab       Date:  1997-08       Impact factor: 5.958

3.  Timing of hormone therapy and dementia: the critical window theory revisited.

Authors:  Rachel A Whitmer; Charles P Quesenberry; Jufen Zhou; Kristine Yaffe
Journal:  Ann Neurol       Date:  2010-11-12       Impact factor: 10.422

4.  Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women.

Authors:  Fernand Labrie; Alain Bélanger; Patrick Bélanger; René Bérubé; Céline Martel; Leonello Cusan; José Gomez; Bernard Candas; Isabelle Castiel; Véronique Chaussade; Claire Deloche; Jacques Leclaire
Journal:  J Steroid Biochem Mol Biol       Date:  2006-04-18       Impact factor: 4.292

5.  Endogenous androgens and cardiovascular risk.

Authors:  Robert A Wild
Journal:  Menopause       Date:  2007 Jul-Aug       Impact factor: 2.953

6.  Can women be identified that will derive considerable cardiovascular benefits from postmenopausal estrogen therapy?

Authors:  Thomas B Clarkson
Journal:  J Clin Endocrinol Metab       Date:  2008-01       Impact factor: 5.958

7.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

8.  Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.

Authors:  Roksana Karim; Howard N Hodis; Frank Z Stanczyk; Rogerio A Lobo; Wendy J Mack
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

9.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.